{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:28:37Z","timestamp":1794281317670,"version":"4.9.0"},"reference-count":160,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.1080\/14737140.2025.2599893","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:09:59Z","timestamp":1766578199000},"page":"437-450","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Targeting angiogenesis in cancer therapy: lessons learned and paths forward"],"prefix":"10.1080","volume":"26","author":[{"given":"Kathrine S.","family":"Rallis","sequence":"first","affiliation":[{"name":"Queen Mary University of London","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/jhmas\/XXXIII.4.531"},{"key":"e_1_3_4_4_1","unstructured":"Contrary to nature: cancer: amazon.co.uk: shimkin M.B.: 9780719400124: books [Internet]. [cited 2021 Jun 4]. Available from: https:\/\/www.amazon.co.uk\/Contrary-Nature-Cancer-M-B-Shimkin\/dp\/0719400120"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030639"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/aja.1000020402"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-016-3680-1"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197111182852108"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197203000-00014"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240290402"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/08977199009011010"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2018.14"},{"issue":"5","key":"e_1_3_4_13_1","first-page":"1417","article-title":"Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis","volume":"151","author":"Pezzella F","year":"1997","unstructured":"Pezzella F, Pastorino U, Tagliabue E, et al. Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol. 1997;151(5):1417\u20131423.","journal-title":"Am J Pathol"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(96)00377-2"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12344"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2011.10.040"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-008-9125-1"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0603-653"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2115"},{"key":"e_1_3_4_21_1","unstructured":"Adair TH Montani J-P. Overview of angiogenesis [Internet]. Angiogenesis. Morgan & Claypool Life Sciences. 2010 [cited 2021 Jun 5]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK53238\/"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3455"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature04478"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines5020034"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1187"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.2006.2.3.213"},{"key":"e_1_3_4_27_1","unstructured":"The lamellipodium: where motility begins: trends in Cell Biology [Internet]. [cited 2021 Jun 7]. Available from: https:\/\/www.cell.com\/trends\/cell-biology\/fulltext\/S0962-8924(01)02237-1?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0962892401022371%3Fshowall%3Dtrue"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01047.2006"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0611177104"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.64"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/380435a0"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1104819"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1152\/nips.01417.2002"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/dvdy.10119"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-003-0784-3"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2004.12.002"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1101\/sqb.2002.67.227"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.07.028"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.186"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.141.7.1659"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1653708"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-3-356"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0181-9"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/587259"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1147"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-013-0015-2"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01088-0"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0706596"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2442"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.21"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2012.03.008"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.01.021"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.02.020"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.08.038"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24227"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1593\/neo.10804"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2009.11.003"},{"issue":"4","key":"e_1_3_4_58_1","first-page":"393","article-title":"Beyond anti-VEGF: dual-targeting antiangiogenic and antiproliferative therapy","volume":"5","author":"Chen C-T","year":"2013","unstructured":"Chen C-T, Hung M-C. Beyond anti-VEGF: dual-targeting antiangiogenic and antiproliferative therapy. Am J Transl Res. 2013;5(4):393\u2013403.","journal-title":"Am J Transl Res"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.09.005"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-3965"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.06.059"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1323"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65173-5"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09624"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09557"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4904"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101402"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5196"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0914072107"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw030"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.01.027"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0575"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-012-9291-z"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4052"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.01.015"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2011.n.002"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.196774"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01400"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104390"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.1612"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-247"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00519"},{"key":"e_1_3_4_83_1","unstructured":"Escalante CP Escalante CP. Angiogenesis inhibitor induced thromboembolism in cancer patients. [cited 2021 Jun 7]"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00020"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-011-0204-7"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33119"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318168d228"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00067.2017"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2016.11.003"},{"issue":"7","key":"e_1_3_4_90_1","first-page":"437","article-title":"Bevacizumab-induced bowel perforation","volume":"111","author":"Sliesoraitis S","year":"2011","unstructured":"Sliesoraitis S, Tawfik B. Bevacizumab-induced bowel perforation. J Am Osteopath Assoc. 2011;111(7):437\u2013441.","journal-title":"J Am Osteopath Assoc"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.06.004"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.02.052"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1080\/02841860701765675"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.04.021"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc070327"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2006.0308"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0586"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djk008"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03253.x"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(12)70016-6"},{"key":"e_1_3_4_101_1","unstructured":"Osteonecrosis of the jaw related to bevacizumab. Journal of Clinical Oncology [Internet]. [cited 2021 Jun 6]. Available from: https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2007.15.5424?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.11.001"},{"key":"e_1_3_4_103_1","doi-asserted-by":"crossref","unstructured":"Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy | nephrology dialysis transplantation | Oxford Academic [Internet]. [cited 2021 Jun 6]. Available from: https:\/\/academic.oup.com\/ndt\/article\/25\/3\/1001\/1914625","DOI":"10.1093\/ndt\/gfp666"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0084-3873(12)00201-5"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.30"},{"key":"e_1_3_4_106_1","unstructured":"Circulating vascular endothelial growth factor (VEGF) as a biomarker for bevacizumab-based therapy in metastatic colorectal non-small cell lung and renal cell cancers: analysis of phase III studies. | Journal of Clinical Oncology [Internet]. [cited 2021 Jun 6]. Available from: https:\/\/ascopubs.org\/doi\/10.1200\/jco.2010.28.15_suppl.10519"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0029"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm988"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1294"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.9908"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.30.15_suppl.1026"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.1771"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.11.021"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.3988"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026331"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.2217\/cns.12.29"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605483"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.581007"},{"key":"e_1_3_4_119_1","unstructured":"7154 poster hypothyroidism and macrocytosis as surrogate markers for response and survival in patients with advanced renal cell carcinoma treated with sunitinib as first-line therapy -. European journal of cancer [Internet]. [cited 2021 Jun 6]. Available from: https:\/\/www.ejcancer.com\/article\/S0959-8049(11)72069-X\/pdf"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25422"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2008.26.15_suppl.5126"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2014.10.002"},{"key":"e_1_3_4_123_1","first-page":"4","article-title":"Pazopanib in metastatic renal cancer: a \u201creal-world\u201d experience at National Cancer Institute \u201cFondazione G. Pascale","volume":"7","author":"Cecere SC","year":"2016","unstructured":"Cecere SC, Rossetti S, Cavaliere C, et al. Pazopanib in metastatic renal cancer: a \u201creal-world\u201d experience at National Cancer Institute \u201cFondazione G. Pascale. Front Pharmacol [Internet]. 2016 [cited 2021 Jun 6];7:4.","journal-title":"Front Pharmacol"},{"key":"e_1_3_4_124_1","unstructured":"Evaluation of hand-foot syndrome (HFS) as a potential biomarker of sunitinib (SU) efficacy in patients (pts) with metastatic renal cell carcinoma (mRCC) and gastrointestinal stromal tumor (GIST). J Clin Oncol [Internet]. [cited 2021 Jun 6]. Available from: https:\/\/ascopubs.org\/doi\/abs\/10.1200\/jco.2011.29.15_suppl.e21113"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.27.15_suppl.3565"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0078"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.9"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3907"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-1956"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25173900"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.65"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv209"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0153"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2017.00101"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01321"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30081-0"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816714"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.01.040"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-012-9500-6"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-019-09698-6"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4197"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12329"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005857"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0138-8"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1742"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-0011"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_4_148_1","unstructured":"Cancer risk statistics [Internet]. Cancer Res. (UK); 2015 [cited 2021 Jun 4]. Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/risk"},{"key":"e_1_3_4_149_1","unstructured":"RePORT [Internet]. [cited 2021 Jun 5]. Available from: https:\/\/report.nih.gov\/funding\/categorical-spending#\/"},{"key":"e_1_3_4_150_1","unstructured":"Janssen Research & Development LLC. A phase 1 first-in-human open-label dose escalation study of Duvortuxizumab a humanized CD19 x CD3 dual-affinity re-targeting (DART\u00ae) protein in subjects with relapsed or refractory B-cell malignancies. Report no.: NCT02454270. Available from clinicaltrials.gov; 2018 [cited 2021 Jun 3]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02454270"},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1277"},{"key":"e_1_3_4_152_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072113"},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060655"},{"key":"e_1_3_4_154_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp177"},{"key":"e_1_3_4_155_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx053"},{"key":"e_1_3_4_156_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.3601"},{"key":"e_1_3_4_157_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.0462"},{"key":"e_1_3_4_158_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.26.4.1197-a"},{"key":"e_1_3_4_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.07.002"},{"key":"e_1_3_4_160_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00758-2"},{"key":"e_1_3_4_161_1","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab293"},{"key":"e_1_3_4_162_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.105"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2025.2599893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:35:26Z","timestamp":1775039726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2025.2599893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":160,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,3]]}},"alternative-id":["10.1080\/14737140.2025.2599893"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2025.2599893","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}